Clinical Trial Update: A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating HSK31858 in participants with non-cystic fibrosis bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• HSK31858 (HSK31858)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Non-cystic Fibrosis Bronchiectasis (NCFBE) | Phase 2 | Status: COMPLETED